Cephalexin
- Product NDC
- 0093-3145
- 11-digit product format
- 000933145
- Labeler code
- 0093
- Product ID
- 0093-3145_c75c0bb6-fe3e-43c6-bdde-edd904731795
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cephalexin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA062702
- Marketing category
- ANDA
- Marketing start
- 1990-09-30
- Substance
- CEPHALEXIN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cephalexin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEPHALEXIN | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | OBN7UDS42Y |
| Rxcui | 309110, 309112, 309113, 309114 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-3145-01 | Cephalexin | 100 in 1 BOTTLE | CAPSULE | 100 | | 26 |
| 0093-3145-05 | Cephalexin | 500 in 1 BOTTLE | CAPSULE | 500 | | 26 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| HYPROMELLOSE 2910 (3 MPA.S) | INACTIVE INGREDIENT | 0VUT3PMY82 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-3145 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA, INC.] | 26 | Current NDC, Legacy NDC, 2 package rows | 20220316_19307ff0-71de-477b-965d-ea243e5ede3a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3145-01 | 00093314501 | 100 CAPSULE in 1 BOTTLE (0093-3145-01) | 100 capsule | 1990-09-30 | 0000-00-00 | No | No | Current |
| 0093-3145-05 | 00093314505 | 500 CAPSULE in 1 BOTTLE (0093-3145-05) | 500 capsule | 1990-09-30 | 0000-00-00 | No | No | Current |